Zosano Pharma Corporation (NASDAQ:ZSAN) reports Quarterly Earnings: Stock Surges 30% in a Week
Clinical stage biopharmaceutical firm Zosano Pharma Corporation (NASDAQ:ZSAN) saw its stock make a big move over the course of the past week as it clocked gains of as much as 30% during the period. While the gains made by the stock were considerable, it ought to be noted that there was no news about the company last week. Trading Data On Friday, ZSAN stock fell 8.16% to $0.2320 with more…